Physician profile
Richard Sauer
NPI 1649322033
$3,960.07
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,734 · 2020: $111 · 2023: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $795.69 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $591.90 | 2019 | |
| Ucb, INC. | $329.72 | 2019 | |
| Greenwich Biosciences, INC. | $256.76 | 2019 | |
| Genzyme Corporation | $256.55 | 2019 | |
| Mdd US Operations, LLC | $207.98 | 2019 | |
| Acadia Pharmaceuticals INC | $190.77 | 2019 | |
| Biogen, INC. | $169.08 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.48 | 2019 | |
| Livanova USA, INC. | $145.70 | 2019 | |
| Sunovion Pharmaceuticals INC. | $144.20 | 2019 | |
| Lilly USA, LLC | $114.04 | 2019 | |
| Supernus Pharmaceuticals, INC. | $101.33 | 2019 | |
| Mallinckrodt Enterprises LLC | $99.26 | 2019 | |
| Eisai INC. | $94.10 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $71.98 | 2019 | |
| Alexion Pharmaceuticals, INC. | $69.45 | 2019 | |
| Lundbeck LLC | $42.49 | 2019 | |
| Allergan, INC. | $39.79 | 2019 | |
| Tanabe Pharma America, INC. | $39.45 | 2019 | |
| Acorda Therapeutics, INC | $21.79 | 2019 | |
| Adamas Pharmaceuticals, INC. | $18.32 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Sauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.